These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21724680)

  • 1. Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases.
    Westerink J; van der Graaf Y; Faber DR; Spiering W; Visseren FL;
    Eur J Prev Cardiol; 2012 Aug; 19(4):864-73. PubMed ID: 21724680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease.
    Kanhai DA; Kappelle LJ; van der Graaf Y; Uiterwaal CS; Visseren FL;
    Int J Obes (Lond); 2012 May; 36(5):695-702. PubMed ID: 21712810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
    Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
    Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of obesity-related hypertension and risk for new vascular events in patients with vascular diseases.
    Vernooij JW; van der Graaf Y; Visseren FL; Spiering W;
    Obesity (Silver Spring); 2012 Oct; 20(10):2118-23. PubMed ID: 22517513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Serum Thyrotropin Levels and Mortality Among Euthyroid Adults in the United States.
    Inoue K; Tsujimoto T; Saito J; Sugiyama T
    Thyroid; 2016 Oct; 26(10):1457-1465. PubMed ID: 27539006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease.
    Westerink J; van der Graaf Y; Faber DR; Visseren FL;
    Eur J Clin Invest; 2011 Feb; 41(2):159-66. PubMed ID: 21039443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease.
    van der Leeuw J; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle LJ; Visseren FL;
    Heart; 2014 Sep; 100(18):1421-9. PubMed ID: 24817441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease.
    Kanhai DA; Visseren FL; van der Graaf Y; Schoneveld AH; Catanzariti LM; Timmers L; Kappelle LJ; Uiterwaal CS; Lim SK; Sze SK; Pasterkamp G; de Kleijn DP;
    Int J Cardiol; 2013 Oct; 168(3):2358-63. PubMed ID: 23484740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
    Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of resting heart rate on vascular events and mortality in vascular patients.
    Bemelmans RH; van der Graaf Y; Nathoe HM; Wassink AM; Vernooij JW; Spiering W; Visseren FL;
    Int J Cardiol; 2013 Sep; 168(2):1410-5. PubMed ID: 23305859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults.
    Tseng FY; Lin WY; Lin CC; Lee LT; Li TC; Sung PK; Huang KC
    J Am Coll Cardiol; 2012 Aug; 60(8):730-7. PubMed ID: 22726629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular events in thyroid disease: a population based, prospective study.
    Schultz M; Kistorp C; Raymond I; Dimsits J; Tuxen C; Hildebrandt P; Faber J
    Horm Metab Res; 2011 Aug; 43(9):653-9. PubMed ID: 21823062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway.
    Asvold BO; Bjøro T; Platou C; Vatten LJ
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):911-7. PubMed ID: 22724581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death.
    Rodondi N; Newman AB; Vittinghoff E; de Rekeneire N; Satterfield S; Harris TB; Bauer DC
    Arch Intern Med; 2005 Nov; 165(21):2460-6. PubMed ID: 16314541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.
    Singh S; Duggal J; Molnar J; Maldonado F; Barsano CP; Arora R
    Int J Cardiol; 2008 Mar; 125(1):41-8. PubMed ID: 17434631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.
    Journy NMY; Bernier MO; Doody MM; Alexander BH; Linet MS; Kitahara CM
    Thyroid; 2017 Aug; 27(8):1001-1010. PubMed ID: 28578598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study.
    Dijk JM; van der Graaf Y; Bots ML; Grobbee DE; Algra A
    Eur Heart J; 2006 Aug; 27(16):1971-8. PubMed ID: 16835264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of thyroid disease in patients with obstructive sleep apnea.
    Bahammam SA; Sharif MM; Jammah AA; Bahammam AS
    Respir Med; 2011 Nov; 105(11):1755-60. PubMed ID: 21820299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.